Why 932 Out of 1000 Portfolios Failed? | Pharma Stocks Deep Dive | Wealth Talk
Join our WhatsApp Channel and vote in the next industry poll – Help shape the next Wealth Talk!
https://whatsapp.com/channel/0029Vb5K6jY9mrGm7cdjmO41
In this week's Wealth Talk, we break a popular myth: "Stock picking is the key to success."
We show how 932 out of 1000 randomly generated Nifty50-based portfolios failed — proving why portfolio approach is far better than stock approach.
📊 Key Segments Covered:
Why most portfolios underperform despite popular stock selections
Random Portfolio Simulation Results & Analysis
Detailed comparison between stock-centric and portfolio-centric investing
Big reveal: WhatsApp Channel Launch 🚀 (1300+ joined in one day!)
Poll Results: Pharma Industry was the top choice
📈 In-depth analysis of 40+ Pharma Stocks across large-cap, mid-cap, and emerging players
🧪 Pharma Stocks Analyzed Include:
Lupin, Mankind Pharma, Sun Pharma, Cipla, Dr. Reddy’s, Gland Pharma, Divi’s Labs, Zydus Lifesciences, Torrent Pharma, Abbott India, Ajanta Pharma, Jubilant Pharmova, Alembic, Themis Medicare, Caplin Point, and many more.
🗳️ Join our WhatsApp Channel and vote in the next industry poll – Help shape the next Wealth Talk!
For more information about any of Vivekam services or offerings, please reach out on
Email: info@vivekam.co.in
Call us: +91 9100009891
----------------------------------------------------------------------------------------------------------------------------------------
Visit website ►: https://www.vivekam.co.in/
#Vivekamzone #financialadvisors #vivekamfinancialservices #WealthTalk #PharmaStocks #StockMarketIndia #PortfolioStrategy #InvestSmart #Nifty50 #PharmaceuticalIndustry #IndianStockMarket #PortfolioVsStock #MarketAnalysis #WhatsAppChannel #Lupin #MankindPharma #MarksansPharma #MorepenLabs #NeulandLabs #NovartisIndia #PiramalEnterprises #RPGLifeSciences #SanofiIndia #SequentScientific #SolaraPharma #StridesPharma #SunPharma #SyncomFormulations #ThemisMedicare #TorrentPharma #UnichemLabs #VinatiOrganics #WindlasBiotech #ZydusLifesciences #AartiPharmalabs #AbbottIndia #AjantaPharma #Alembic #AlembicPharma #AlivusLifeSciences #Amrutanjan #BlissGVS #CaplinPoint #Cipla #DishmanCarbogen #DivisLabs #DrReddysLabs #ERISLifesciences #GlandPharma #GSKPharma #HesterBiosciences #Hikal #JagsonpalPharma #JubilantPharmova #LongTermInvesting #IndianPharma #FundamentalAnalysis #MarketSentiment #StockMarketTips
Видео Why 932 Out of 1000 Portfolios Failed? | Pharma Stocks Deep Dive | Wealth Talk канала vivekamzone
https://whatsapp.com/channel/0029Vb5K6jY9mrGm7cdjmO41
In this week's Wealth Talk, we break a popular myth: "Stock picking is the key to success."
We show how 932 out of 1000 randomly generated Nifty50-based portfolios failed — proving why portfolio approach is far better than stock approach.
📊 Key Segments Covered:
Why most portfolios underperform despite popular stock selections
Random Portfolio Simulation Results & Analysis
Detailed comparison between stock-centric and portfolio-centric investing
Big reveal: WhatsApp Channel Launch 🚀 (1300+ joined in one day!)
Poll Results: Pharma Industry was the top choice
📈 In-depth analysis of 40+ Pharma Stocks across large-cap, mid-cap, and emerging players
🧪 Pharma Stocks Analyzed Include:
Lupin, Mankind Pharma, Sun Pharma, Cipla, Dr. Reddy’s, Gland Pharma, Divi’s Labs, Zydus Lifesciences, Torrent Pharma, Abbott India, Ajanta Pharma, Jubilant Pharmova, Alembic, Themis Medicare, Caplin Point, and many more.
🗳️ Join our WhatsApp Channel and vote in the next industry poll – Help shape the next Wealth Talk!
For more information about any of Vivekam services or offerings, please reach out on
Email: info@vivekam.co.in
Call us: +91 9100009891
----------------------------------------------------------------------------------------------------------------------------------------
Visit website ►: https://www.vivekam.co.in/
#Vivekamzone #financialadvisors #vivekamfinancialservices #WealthTalk #PharmaStocks #StockMarketIndia #PortfolioStrategy #InvestSmart #Nifty50 #PharmaceuticalIndustry #IndianStockMarket #PortfolioVsStock #MarketAnalysis #WhatsAppChannel #Lupin #MankindPharma #MarksansPharma #MorepenLabs #NeulandLabs #NovartisIndia #PiramalEnterprises #RPGLifeSciences #SanofiIndia #SequentScientific #SolaraPharma #StridesPharma #SunPharma #SyncomFormulations #ThemisMedicare #TorrentPharma #UnichemLabs #VinatiOrganics #WindlasBiotech #ZydusLifesciences #AartiPharmalabs #AbbottIndia #AjantaPharma #Alembic #AlembicPharma #AlivusLifeSciences #Amrutanjan #BlissGVS #CaplinPoint #Cipla #DishmanCarbogen #DivisLabs #DrReddysLabs #ERISLifesciences #GlandPharma #GSKPharma #HesterBiosciences #Hikal #JagsonpalPharma #JubilantPharmova #LongTermInvesting #IndianPharma #FundamentalAnalysis #MarketSentiment #StockMarketTips
Видео Why 932 Out of 1000 Portfolios Failed? | Pharma Stocks Deep Dive | Wealth Talk канала vivekamzone
vivekamzone vivekam NSE BSE share market profit your trade nse india national stock exchange portfolio shares stock market investments nse 500 index nifty 500 index pharmaceuticals stocks tejas network Tata motors Rattan India buy & hold returns nifty buying & selling long term equity market market volatality dr reddy's laboratories divis labs laurus labs profits holdings profit and loss trump tariffs tariffs small caps large caps aarti pharmalabs
Комментарии отсутствуют
Информация о видео
24 мая 2025 г. 10:30:06
00:28:42
Другие видео канала
